Life Sciences Report Collection
The Life Sciences Collection spans markets that are central to the life and wellbeing of the more than 7.5 billion people on our planet. From emerging diagnostics, to brand new therapies and treatment technologies, our expert analysts know where your focus – and investment – should be when it comes to biotechnology, pharmaceuticals and healthcare. As your senior editor, I look forward to introducing you to new opportunities.
These reports emphasize markets where technologies intersect with the building blocks of human life, including DNA, RNA, cancer, genomics, genetics, molecular diagnostics and more.
Globally, healthcare constitutes a multi trillion-dollar industry. Reports in this category span the range of treatments, administration practices and technologies available around the world.
Enormously important intersection of engineering, tissue manipulation, the surgeons scalpel and design. Specialist companies target well known and also the barely pronounceable conditions.
The global market for blockchain technology in healthcare applications should grow from $140.0 million in 2019 to $1.4 billion by 2024 at a compound annual growth rate (CAGR) of 58.2% during the forecast period, 2019-2024.
This report will review the current commercial and regulatory landscape for the stem cell therapies, and assesses the challenges and opportunities for developing autologous and allogenic “off the shelf” solutions to treat a broad range of diseases and injuries.
In the context of the huge impact of generic drug development and its implication in cost savings, an attempt has been made to analyze various pharmaceutical original products which experience patent expiry and likely to go off patents. The report also covers a section illustrating the case for development and opportunities that lie for manufacturers engaged in the generic or biosimilar business for the key drugs.
The global market for dental equipment, materials and supplies should grow from $60.5 billion in 2019 to reach $70.8 billion by 2024 at a compound annual growth rate (CAGR) of 3.2% for the period of 2019-2024.
This report is designed to investigate recent years of performance of pharmaceutical and biopharmaceutical companies with respect to return on investment (ROI) in research and development (R&D), and to discuss ways that companies are trying to improve ROI through 2024. Investigation will include Country/Regional market trends with top areas of return, 2014-2024. This report also looks at which companies are already using artificial intelligence (AI) and machine learning (ML) to successfully compete globally.
The global synthetic biology market should grow from $5.3 billion in 2019 to $18.9 billion by 2024 with a compound annual growth rate (CAGR) of 28.8% for the period of 2019-2024.
Medical imaging is playing an increasingly important role in modern healthcare where it is used for non-invasive diagnostics, therapy planning, and follow-up evaluations. This report provides a market outlook of 4D imaging in healthcare along with current and emerging trends. It also looks at the various activities in progress that are expected to create new opportunities for 4D imaging in the fields of telemedicine and patient self-testing.
The global market for electromedical devices reached $41.3 billion in 2018 and should reach $58.5 billion by 2023, at a compound annual growth rate (CAGR) of 7.2% for the period of 2018-2023.
The global pediatric market should grow from $92.6 billion in 2019 to reach $116.6 billion by 2024 at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2024.
The global blood transfusion market should grow from $5.9 billion in 2018 to $7.6 billion by 2023 with a compound annual growth rate (CAGR) of 5.1% for the period of 2018-2023.
The global breast cancer diagnostic and drug market should reach $28.2 billion by 2024 from $20.9 billion in 2019 at a compound annual growth rate (CAGR) of 6.2% for the forecast period of 2019 to 2024.
This BCC Research Review is a collection of highlights from several healthcare market research reports that were published in 2019.
This Biotechnology Research Review provides a sampling of the type of quantitative market information, analysis and guidance.
The global market for chronic disease management therapeutics and device technologies should grow from $346 billion in 2019 to $490 billion by 2024, at a compound annual growth rate (CAGR) of 7.2% from 2019 through 2024.
The global bioinformatics market should grow from $7.5 billion in 2018 to $20.0 billion by 2023, with a compound annual growth rate (CAGR) of 21.7% during the period of 2018-2023.
The global cannabis market should grow from $25.6 billion in 2019 to $77.6 billion by 2024 at a compound annual growth rate (CAGR) of 24.8% for the period of 2019-2024.
The global market for electroceuticals should grow from $27.6 billion in 2019 to $39.2 billion by 2024 at a compound annual growth rate (CAGR) of 7.3% for the period of 2019-2024.
The global bionic devices market should reach $6.2 billion by 2024 and $11.3 billion by 2029 from $3.7 billion in 2019 at compound annual growth rates (CAGRs) of 11.1% and 12.8% for the period of 2019 to 2024 and 2024 to 2029, respectively.
The global surgical devices market should grow from $85.5 billion in 2019 to reach $138.5 billion by 2024 at a compound annual growth rate (CAGR) of 10.1% for the period of 2019-2024.
Western blotting is the one of the most widely-used methods for protein identification and relative quantitation. This report will look at the application areas and market dynamics of western blotting market.
This comprehensive report provides an in-depth assessment of the global market for predisposition biomarker technologies. The report’s key objective is to analyze areas of opportunities, key developments and the impact of this technology on industry, specifically the pharmaceutical, biotechnology and healthcare sectors. The analysis also reviews the adoption of predisposition biomarker technologies in developed and emerging markets.
The global market for cryostat microtome should grow from $43.4 million in 2019 to $60.6 million by 2024 with a compound annual growth rate (CAGR) of 6.9% for the period of 2019-2024.
This report on Over-the-Counter (OTC) drugs and dietary supplement products market highlights primary healthcare and its various parameters such as the drafting of rules and regulations for OTC drugs and dietary supplements, the number of drugs classified, self-care awareness among consumers and the size of distribution networks, OTC drugs and dietary supplements manufacturers. BCC Research analyzed key categories and regions to determine the present and future OTC drugs and dietary supplement products market status and forecasted market growth.
The global market for MIS devices and equipment sales should grow from $21.2 billion in 2019 to $29.9 billion by 2024 with a compound annual growth rate (CAGR) of 7.1% for the period of 2019-2024.
The report provides a brief description of global market for medical wearables beyond FitBit and how these medical wearables devices monitor blood sugar, glucose, and chronic diseases like heart diseases, diabetes, and various other parameters.
Get an outlook on the HTA process and its approvals in major pharma industries.
This report provides an overview of global CRISPR market, discussion on CRISPR interference technique and its potential application in alteration of germline of animal, human and other organisms
Get an overview of the current state of the art for Continuous Glucose Monitoring (CGM) for diabetes.
Get an overview of R&D, economic impact and future implications for global market due to COVID-19.
The report will provide details about the pain management drugs used in the form of patches for immediate relief from any type of pain.
The current report provides detailed exposure to the sternal closure devices market.
The current report provides detailed competitive landscape of top 100 medical device manufacturers in the global market.
Examine 3D cell cultures technologies with current market status, future market drivers and its growth potential over the five-year period from 2019 to 2024.
This report evaluates the effect of strategic factors such as technology-driven change and industry consolidation on the antifungal drugs market. it also provides information on the current market dynamics and factors influencing the future growth opportunities in the antifungal drugs market.
This report provides comprehensive analysis of biologics, or biopharmaceuticals, on a global basis. it also gives information, from detailed product analyses within disease subsegments to overall industry trends.
Get a comprehensive view of the global markets for natural language processing (NLP) in healthcare industry.
Get an overview of the global markets for over-the-counter (OTC) drugs, medical devices and diagnostics. Analyses of global market trends with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2024.
An overview of the global markets for pharmaceuticals, specifically healthcare legislation and regulation, pricing mechanisms, and reimbursement procedures.
Get an analysis of the advanced drug delivery market by technology systems, applications, routes of administration, and drug delivery vehicles.
Get an overview of the global markets and technologies for rare disease diagnostics and discussion on market opportunities for these technologies.
Detailed review of artificial intelligence (AI) applications in the diagnosis and treatment of cancer diseases. Coverage of different AI algorithm types -- artificial neural networks and deep learning -- and their feasible healthcare applications in the field of cancer
Get an overview of the global outsourcing market for drug and medical device development and discussion on their services and technologies.
Get an overview of global market for cell and gene therapy tools and information on their importance in treating human health.
An overview of the artificial intelligence (AI) applications in fighting against HIV/AIDS-related illnesses. Discussion of recent achievements and breakthrough therapies related to HIV/AIDS disease segments.
PCR for POC Diagnostics
BCC Research analyst Todd Graham delves into the markets being served by the new technology for polymerase chain reaction for point-of-care diagnostics, sharing the uses, outlook, and more on these clinical diagnostic kits. Recorded live on May 16, 2018.
How to Dissect a Market Opportunity
BCC Research Senior Editor Gordon Nameni shares how to interpret market research to uncover market opportunities at a live event on September 12, 2017, in Boston, MA.